Related Experiment Video

Updated: Aug 5, 2026

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
10:03

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

Published on: August 1, 2013

Cuban COVID-19 Vaccines for Children: Rinaldo Puga MD MS Principal Investigator, Pediatric Clinical Trials for

Gail Reed1

  • 1Journalist and Executive Editor, MEDICC Review.

MEDICC Review
|February 14, 2022
PubMed

Insights

Cuba vaccinated over 1.7 million children against COVID-19 using Soberana vaccines. Clinical trials demonstrated the safety and efficacy of these pediatric vaccines, supporting widespread immunization efforts.

Area of Science:

  • Pediatric infectious diseases
  • Vaccinology
  • Public health policy

Background:

  • Cuba initiated a large-scale COVID-19 vaccination campaign for children aged 2-18 in September 2021.
  • This initiative aimed to protect a vulnerable population during a global surge in pediatric COVID-19 hospitalizations.

Discussion:

  • The article explores the rationale behind Cuba's decision to vaccinate children against COVID-19.
  • It details the clinical trials, including Phase 1/2 studies, for the Soberana 02 and Soberana Plus vaccines in pediatric populations.
  • Expert insights from Dr. Rinaldo Puga, principal investigator, are presented.

Key Insights:

  • Approximately two million Cuban children and adolescents received Soberana vaccines.
  • The vaccination campaign achieved high coverage, immunizing 81.3% of the target population by December 2021.
  • The study provides evidence on the safety and effectiveness of COVID-19 vaccination in young individuals.

Outlook:

  • The findings contribute to the global understanding of pediatric COVID-19 vaccination strategies.
  • Cuba's experience offers valuable data for public health authorities worldwide considering similar initiatives.
  • Further research may explore long-term efficacy and impact on disease transmission.

More Related Videos

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...